Pharmacopeia (PCOP) Tops Q3 View By 20c
Pharmacopeia (Nasdaq: PCOP) reports Q3 loss of $0.25, 20 cents better than the analyst estimate of ($0.45). Revenue for the quarter was $5.9 million, versus the consensus of $6.15 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
